155 related articles for article (PubMed ID: 31734202)
1. Antimalarial-Induced Cardiomyopathy Resembles Fabry Disease on Cardiac MRI.
Hanneman K; Alberdi HV; Karur GR; Tselios K; Harvey PJ; Gladman DD; Akhtari S; Osuntokun T; Wald RM; Thavendiranathan P; Butany J; Urowitz MB
JACC Cardiovasc Imaging; 2020 Mar; 13(3):879-881. PubMed ID: 31734202
[No Abstract] [Full Text] [Related]
2. Heart Involvement in a Woman Treated with Hydroxychloroquine for Systemic Lupus Erythematosus Revealing Fabry Disease.
Chatre C; Filippi N; Roubille F; Pers YM
J Rheumatol; 2016 May; 43(5):997-8. PubMed ID: 27134281
[No Abstract] [Full Text] [Related]
3. Chloroquine cardiotoxicity: clinicopathologic features in three patients and comparison with three patients with Fabry disease.
Roos JM; Aubry MC; Edwards WD
Cardiovasc Pathol; 2002; 11(5):277-83. PubMed ID: 12361838
[TBL] [Abstract][Full Text] [Related]
4. Hydroxychloroquine-Induced Cardiomyopathy in Systemic Lupus Erythematosus.
Tselios K; Gladman DD; Harvey P; Mak S; Chantal M; Butany J; Urowitz MB
J Clin Rheumatol; 2016 Aug; 22(5):287-8. PubMed ID: 27464781
[No Abstract] [Full Text] [Related]
5. Diagnosis of chloroquine cardiomyopathy by endomyocardial biopsy.
Ratliff NB; Estes ML; Myles JL; Shirey EK; McMahon JT
N Engl J Med; 1987 Jan; 316(4):191-3. PubMed ID: 3796692
[No Abstract] [Full Text] [Related]
6. Fatal antimalarial-induced cardiomyopathy: report of 2 cases.
Azimian M; Gultekin SH; Hata JL; Atkinson JB; Ely KA; Fuchs HA; Mobley BC
J Clin Rheumatol; 2012 Oct; 18(7):363-6. PubMed ID: 23047537
[TBL] [Abstract][Full Text] [Related]
7. Chloroquine-induced cardiomyopathy: a reversible cause of heart failure.
Yogasundaram H; Hung W; Paterson ID; Sergi C; Oudit GY
ESC Heart Fail; 2018 Jun; 5(3):372-375. PubMed ID: 29460476
[TBL] [Abstract][Full Text] [Related]
8. Cardiac Magnetic Resonance Imaging and Clinical Follow-up in Antimalarial-induced Cardiomyopathy in Patients With Systemic Lupus Erythematosus.
Shalmon T; Thavendiranathan P; Harvey P; Akhtari S; Tselios K; Gladman DD; Hanneman K
J Thorac Imaging; 2023 May; 38(3):W30-W32. PubMed ID: 36728467
[TBL] [Abstract][Full Text] [Related]
9. [Eye toxicity of antimalarial agents].
Graña Gil J; Cabana Vázquez M; Vázquez González A; Sánchez Meizoso MO
An Med Interna; 2002 Apr; 19(4):189-91. PubMed ID: 12090061
[TBL] [Abstract][Full Text] [Related]
10. Hydroxychloroquine-induced restrictive cardiomyopathy: a case report.
Dogar MU; Shah NN; Ishtiaq S; Shah PN; Shah P; Mathew S; Vittorio TJ
Postgrad Med J; 2018 Mar; 94(1109):185-186. PubMed ID: 29353247
[No Abstract] [Full Text] [Related]
11. Antimalarial-induced Cardiomyopathy in Systemic Lupus Erythematosus: As Rare as Considered?
Tselios K; Deeb M; Gladman DD; Harvey P; Akhtari S; Mak S; Butany J; Urowitz MB
J Rheumatol; 2019 Apr; 46(4):391-396. PubMed ID: 30323009
[TBL] [Abstract][Full Text] [Related]
12. Chloroquine, Hydroxychloroquine and Hearing Loss: A Study in Systemic Lupus Erythematosus Patients.
Polanski JF; Tanaka EA; Barros H; Chuchene AG; Miguel PTG; Skare TL
Laryngoscope; 2021 Mar; 131(3):E957-E960. PubMed ID: 32603516
[TBL] [Abstract][Full Text] [Related]
13. Antimalarial drug-induced aquagenic-type pruritus in patients with lupus.
Jiménez-Alonso J; Tercedor J; Jáimez L; García-Lora E
Arthritis Rheum; 1998 Apr; 41(4):744-5. PubMed ID: 9550488
[No Abstract] [Full Text] [Related]
14. Hydroxychloroquine cardiotoxicity in systemic lupus erythematosus: a report of 2 cases and review of the literature.
Nord JE; Shah PK; Rinaldi RZ; Weisman MH
Semin Arthritis Rheum; 2004 Apr; 33(5):336-51. PubMed ID: 15079764
[TBL] [Abstract][Full Text] [Related]
15. Chloroquine cardiomyopathy: beyond ocular adverse effects.
Lopez-Ruiz N; Uribe CE
BMJ Case Rep; 2014 Sep; 2014():. PubMed ID: 25225192
[TBL] [Abstract][Full Text] [Related]
16. Antimalarial drug retinopathy: A typical « Bull's eyes » appearance of fundus.
Guiot A; Couturier M; Tebib JG; Abouaf L; Coury F
Joint Bone Spine; 2018 May; 85(3):369. PubMed ID: 28512007
[No Abstract] [Full Text] [Related]
17. Oral manifestations associated with antimalarial therapy in patients with systemic lupus erythematosus.
Chacón-Dulcey V; López-Labady J; Villarroel-Dorrego M; Frías J; Tirado W; González N; Pérez Alfonzo R
Lupus; 2020 Jun; 29(7):761-766. PubMed ID: 32362181
[TBL] [Abstract][Full Text] [Related]
18. Cardiomyopathy related to antimalarial therapy with illustrative case report.
Costedoat-Chalumeau N; Hulot JS; Amoura Z; Delcourt A; Maisonobe T; Dorent R; Bonnet N; Sablé R; Lechat P; Wechsler B; Piette JC
Cardiology; 2007; 107(2):73-80. PubMed ID: 16804295
[TBL] [Abstract][Full Text] [Related]
19. [A rare cause of impaired general condition: Muscular and cardiac toxicity of antimalarials].
Lenfant T; Dion J; Maisonobe T; Costedoat-Chalumeau N
Rev Med Interne; 2020 May; 41(5):335-338. PubMed ID: 32334861
[TBL] [Abstract][Full Text] [Related]
20. Chloroquine neuromyotoxicity. Clinical and pathologic perspective.
Estes ML; Ewing-Wilson D; Chou SM; Mitsumoto H; Hanson M; Shirey E; Ratliff NB
Am J Med; 1987 Mar; 82(3):447-55. PubMed ID: 3826099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
